Nuvectis Pharma (NVCT) Institutional Ownership $7.53 +0.01 (+0.16%) As of 11:33 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Nuvectis Pharma (NASDAQ:NVCT)CurrentInstitutional OwnershipPercentage96.77%Number ofInstitutional Buyers(last 12 months)20TotalInstitutional Inflows(last 12 months)$7.59MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$378.54K Get NVCT Insider Trade Alerts Want to know when executives and insiders are buying or selling Nuvectis Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NVCT Institutional Buying and Selling by Quarter Nuvectis Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails6/27/2025Goldman Sachs Group Inc.45,608$446K0.0%N/A0.218% 5/19/2025Jane Street Group LLC42,299$413K0.0%N/A0.202% 5/16/2025Goldman Sachs Group Inc.45,608$446K0.0%N/A0.218% 5/15/2025OMERS ADMINISTRATION Corp32,882$321K0.0%N/A0.139% 5/1/2025Austin Wealth Management LLC40,250$393K0.1%N/A0.172% 4/30/2025Iridian Asset Management LLC CT253,972$2.48M0.8%N/A1.086% 4/23/2025Oppenheimer & Co. Inc.41,000$401K0.0%+64.0%0.175% 4/14/2025Baldwin Wealth Partners LLC MA358,461$3.50M0.2%+0.7%1.532% 4/11/2025Blue Zone Wealth Advisors LLC10,424$102K0.0%N/A0.045% 2/17/2025Squarepoint Ops LLC19,071$103K0.0%N/A0.099% Get the Latest News and Ratings for NVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025Two Sigma Investments LP18,570$100K0.0%-30.7%0.096% 2/17/2025Millennium Management LLC29,698$161K0.0%-56.6%0.154% 2/17/2025Cubist Systematic Strategies LLC6,294$34K0.0%N/A0.033% 2/14/2025Northern Trust Corp25,725$139K0.0%+68.7%0.133% 2/13/2025Marshall Wace LLP124,571$674K0.0%+191.0%0.645% 2/12/2025Edmond DE Rothschild Holding S.A.15,170$82K0.0%-20.9%0.079% 2/12/2025Baxter Bros Inc.15,000$81K0.0%+20.0%0.078% 2/5/2025Oppenheimer & Co. Inc.25,000$135K0.0%N/A0.129% 1/30/2025Nations Financial Group Inc. IA ADV13,500$73K0.0%+35.0%0.070% 1/28/2025Forbes J M & Co. LLP59,000$319K0.0%+21.9%0.305% 1/22/2025Baldwin Wealth Partners LLC MA355,961$1.93M0.1%+104.4%1.842% 11/16/2024Geode Capital Management LLC79,716$501K0.0%+49.8%0.413% 11/5/2024GSA Capital Partners LLP50,129$315K0.0%+3.7%0.269% 11/5/2024Nations Financial Group Inc. IA ADV10,000$63K0.0%N/A0.054% 10/25/2024Iridian Asset Management LLC CT55,380$348K0.1%N/A0.297% 9/16/2024Point72 Asia Singapore Pte. Ltd.9,203$58K0.0%N/A0.050% 8/15/2024Point72 Asia Singapore Pte. Ltd.9,203$58K0.0%N/A0.050% 8/14/2024Marshall Wace LLP33,868$214K0.0%-32.4%0.185% 8/9/2024Renaissance Technologies LLC74,500$472K0.0%+20.7%0.406% 7/16/2024Baxter Bros Inc.12,500$79K0.0%N/A0.068% 7/12/2024Baldwin Brothers LLC MA168,630$1.07M0.1%+9.4%0.918% 5/10/2024Vanguard Group Inc.298,800$2.45M0.0%+1.5%1.626% 4/18/2024Blue Zone Wealth Advisors LLC14,350$118K0.0%N/A0.081% 2/12/2024Edmond DE Rothschild Holding S.A.19,170$160K0.0%N/A0.111% 1/30/2024Strs Ohio6,200$51K0.0%+59.0%0.036% 1/8/2024Baldwin Brothers LLC MA142,040$1.19M0.1%+22.0%0.820% 11/2/2023Forbes J M & Co. LLP34,000$438K0.1%-49.3%0.197% 10/26/2023Strs Ohio3,900$50K0.0%+178.6%0.023% 10/10/2023Baldwin Brothers LLC MA116,380$1.50M0.1%+29.2%0.675% 8/10/2023Hollencrest Capital Management3,040$49K0.0%N/A0.019% Trump’s New Order Could Boost Social Security Benefits by 400% (Ad)If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President Trump's Executive Order #14196 could not only save Social Security from collapse... ...but potentially increase benefits by up to 400%, according to legendary investor Louis Navellier.Click here to watch the full presentation before it's too late.8/4/2023American International Group Inc.3,298$53K0.0%N/A0.021% 8/3/2023Forbes J M & Co. LLP67,000$1.07M0.1%N/A0.418% 8/2/2023Bank of Montreal Can11,012$200K0.0%N/A0.069% 7/14/2023Baldwin Brothers LLC MA90,061$1.44M0.1%-37.4%0.563% 5/11/2023Edmond DE Rothschild Holding S.A.24,570$322K0.0%N/A0.167% 4/21/2023Baldwin Brothers LLC MA143,800$1.89M0.2%+7.9%0.975% 11/4/2022Ronit Capital LLP562,547$3.99M5.4%+34.2%3.843% 10/14/2022Baldwin Brothers LLC MA133,000$943K0.1%+9.9%0.908% 8/4/2022Ronit Capital LLP419,282$4.70M6.7%-23.8%3.297% 7/18/2022Baldwin Brothers LLC MA121,000$1.36M0.2%N/A0.951% 5/11/2022Ronit Capital LLP550,000$4.08M5.1%N/A4.325% (Data available from 1/1/2016 forward) NVCT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NVCT shares? During the previous two years, 28 institutional investors and hedge funds held shares of Nuvectis Pharma. The most heavily invested institutionals were Baldwin Wealth Partners LLC MA ($3.50M), Iridian Asset Management LLC CT ($2.48M), Vanguard Group Inc. ($2.45M), Baldwin Brothers LLC MA ($1.07M), Marshall Wace LLP ($674K), Geode Capital Management LLC ($501K), and Renaissance Technologies LLC ($472K).Learn more on Nuvectis Pharma's institutional investors. What percentage of Nuvectis Pharma's stock is owned by institutional investors? 96.77% of Nuvectis Pharma's stock is owned by institutional investors. Learn more on NVCT's institutional investor holdings. Which institutional investors have been buying Nuvectis Pharma's stock? Of the 26 institutional investors that purchased Nuvectis Pharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Iridian Asset Management LLC CT ($309.35K), Baldwin Wealth Partners LLC MA ($184.33K), Goldman Sachs Group Inc. ($91.22K), Marshall Wace LLP ($81.76K), Forbes J M & Co. LLP ($77.60K), Baldwin Brothers LLC MA ($66.48K), and Jane Street Group LLC ($42.30K). How much institutional buying is happening at Nuvectis Pharma? Institutional investors have bought a total of 982,432 shares in the last 24 months. This purchase volume represents approximately $7.59M in transactions. Which of Nuvectis Pharma's major shareholders have been selling company stock? The following institutional investors have sold Nuvectis Pharma stock in the last 24 months: Millennium Management LLC ($38.80K), Marshall Wace LLP ($16.20K), Two Sigma Investments LP ($8.22K), and Edmond DE Rothschild Holding S.A. ($4K). How much institutional selling is happening at Nuvectis Pharma? Institutional investors have sold a total of 67,216 shares in the last 24 months. This volume of shares sold represents approximately $378.54K in transactions. Related Companies URGN Major Shareholders NUVB Major Shareholders IOVA Major Shareholders ABUS Major Shareholders DAWN Major Shareholders GHRS Major Shareholders SION Major Shareholders STOK Major Shareholders CDXC Major Shareholders XNCR Major Shareholders This page (NASDAQ:NVCT) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvectis Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvectis Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
